GISAID EpiFlu - Global Initiative on Sharing All Influenza Data
This platform is designed and maintained by scientists for scientists from various disciplines in influenza research, including veterinary and human virology, bioinformatics, epidemiology, immunology and clinical analysis etc. From here on, you will find a series of services as part of services of our pledge to offer the most complete information on influenza.
We respectfully remind our users when sourcing sequences and related data from this platform to observe the underlying principles enshrined in GISAID, by recognizing the contributions and interests of those providing the data. You are required to acknowledge data contributors (a sample can be found here); You are also required to make best efforts to collaborate with data contributors; You may not attach restrictions on the data to ensure that researchers will have unlimited access to the data; You may not disclose our data outside the GISAID community.
GISAID actively promotes the sharing of all influenza type virus sequences, related clinical and epidemiological data associated with human isolates, and geographic and species-specific data associated with avian and other animal isolates. Researchers from around the globe have come together and agreed to collaborate and to respect the rights & interests of all parties involved.
Admission to GISAID's publicly accessible platform is free-of-charge. It is accessible to anyone who agrees to its basic premise of upholding a scientific etiquette, acknowledging the originating laboratories providing the specimen and submitting laboratories who generate the sequence data, and ensuring fair exploitation of results coming from the data, and that no restrictions shall be attached to data that have been submitted to GISAID.
Admission to GISAID's publicly accessible platform is free-of-charge. It is accessible to anyone who agrees to its basic premise of upholding a scientific etiquette, acknowledging the originating laboratories providing the specimen and submitting laboratories who generate the sequence data, and ensuring fair exploitation of results coming from the data, and that no restrictions shall be attached to data that have been submitted to GISAID.
Featuring the world's most complete collection of influenza sequences containing associated metadata, both clinical & epidemiological. Its functionality continues to be tailored to the needs of influenza researchers from both the human and the veterinary fields.
Conceptualized by the knowledge of influenza scientists, it is powered by developers at the Max-Planck-Institute
Within the first year of its operation, thousands of users have made EpiFluTM database their primary source for novel data that contains a complete collection of all data from other public sources as well as unique data not found elsewhere.
Conceptualized by the knowledge of influenza scientists, it is powered by developers at the Max-Planck-Institute
Within the first year of its operation, thousands of users have made EpiFluTM database their primary source for novel data that contains a complete collection of all data from other public sources as well as unique data not found elsewhere.
To uphold GISAID′s unique sharing mechanism, all users must positively identify themselves. While GISAID data is publicly accessible, it does not fall under the legal definition of Public Domain since GISAID does not remove nor waive any preexisting rights should such rights exist.
This mechanism assures reciprocity of the data for future generations.
This mechanism assures reciprocity of the data for future generations.
GISAID is overseen via a verifiable and unbiased mechanism of organizational bodies that operate independent of each other.
The Government of the Federal Republic of Germany is the official host of the GISAID Platform and EpiFlu™ database.
The Government of the Federal Republic of Germany is the official host of the GISAID Platform and EpiFlu™ database.
.png)
No hay comentarios:
Publicar un comentario